Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-55854 | tai-screen-luciferase | 4.880 | 1.80e-26 | 2.35e-04 | 4.05e-04 | 5 | 3 |
int-snw-7372 | tai-screen-luciferase | 6.242 | 1.24e-129 | 8.55e-07 | 3.77e-03 | 23 | 19 |
reg-snw-60 | tai-screen-luciferase | 4.243 | 1.88e-19 | 3.43e-03 | 4.71e-03 | 12 | 5 |
reg-snw-1964 | tai-screen-luciferase | 4.532 | 1.75e-22 | 1.10e-03 | 1.69e-03 | 7 | 6 |
reg-snw-1121 | tai-screen-luciferase | 4.707 | 1.91e-24 | 5.19e-04 | 8.44e-04 | 5 | 3 |
reg-snw-1500 | tai-screen-luciferase | 4.226 | 2.77e-19 | 3.65e-03 | 4.98e-03 | 9 | 7 |
reg-snw-821 | tai-screen-luciferase | 4.344 | 1.76e-20 | 2.34e-03 | 3.35e-03 | 11 | 4 |
reg-snw-84343 | tai-screen-luciferase | 4.236 | 2.24e-19 | 3.52e-03 | 4.83e-03 | 10 | 5 |
reg-snw-51164 | tai-screen-luciferase | 4.586 | 4.41e-23 | 8.78e-04 | 1.37e-03 | 6 | 4 |
reg-snw-57120 | tai-screen-luciferase | 4.450 | 1.33e-21 | 1.54e-03 | 2.29e-03 | 12 | 6 |
Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | List-Gonzales GI | Tai-Hits |
---|---|---|---|---|---|---|---|
RPS20 | 6224 | 22 | -4.757 | 6.314 | 153 | Yes | - |
RPS15 | 6209 | 30 | -5.040 | 7.011 | 116 | Yes | - |
RPS2 | 6187 | 16 | -3.241 | 4.226 | 13 | Yes | - |
DMD | 1756 | 15 | -4.338 | 4.243 | 53 | - | - |
COPA | 1314 | 48 | -9.395 | 5.672 | 340 | Yes | Yes |
PAFAH1B1 | 5048 | 18 | -2.583 | 4.586 | 55 | Yes | - |
CTSF | 8722 | 8 | -3.978 | 4.236 | 1 | - | Yes |
RPS29 | 6235 | 17 | -8.386 | 6.597 | 29 | - | - |
TNFRSF8 | 943 | 19 | -4.106 | 4.450 | 15 | - | - |
EIF1AX | 1964 | 14 | -3.005 | 4.532 | 43 | Yes | - |
CUL4B | 8450 | 21 | -2.809 | 5.269 | 142 | - | - |
HSF1 | 3297 | 46 | -4.179 | 5.027 | 209 | - | Yes |
ARFGEF1 | 10565 | 13 | -2.722 | 4.344 | 15 | - | - |
PLA2G12A | 81579 | 10 | 2.326 | 6.242 | 9 | - | - |
CANX | 821 | 17 | -1.959 | 4.504 | 65 | - | - |
COPB2 | 9276 | 48 | -13.168 | 9.063 | 41 | Yes | Yes |
CKAP5 | 9793 | 46 | -7.214 | 5.672 | 130 | Yes | Yes |
ATG4C | 84938 | 10 | 2.130 | 6.242 | 321 | - | - |
RB1 | 5925 | 21 | -2.085 | 4.707 | 351 | - | - |
EIF2S2 | 8894 | 31 | -4.320 | 5.672 | 103 | Yes | - |
ZC3H15 | 55854 | 14 | 3.269 | 4.880 | 11 | - | - |
RPS16 | 6217 | 38 | -5.444 | 4.880 | 205 | - | - |
CHM | 1121 | 13 | -0.483 | 4.707 | 2 | - | - |
CDC42 | 998 | 44 | -6.960 | 4.707 | 276 | Yes | Yes |
UTP18 | 51096 | 8 | -1.709 | 4.236 | 106 | - | - |
RPS11 | 6205 | 44 | -6.588 | 7.555 | 175 | Yes | - |
DCTN4 | 51164 | 13 | -1.882 | 4.586 | 19 | - | - |
RPS6 | 6194 | 44 | -5.603 | 8.046 | 217 | Yes | - |
MRPS12 | 6183 | 35 | -5.421 | 5.516 | 341 | Yes | - |
TLK2 | 11011 | 21 | -4.011 | 5.672 | 14 | - | - |
RAN | 5901 | 38 | -3.809 | 4.325 | 258 | Yes | Yes |
COPB1 | 1315 | 39 | -6.221 | 9.063 | 118 | Yes | Yes |
SERBP1 | 26135 | 35 | -4.612 | 5.516 | 106 | - | Yes |
RPS23 | 6228 | 21 | -4.485 | 6.375 | 118 | Yes | - |
RPS13 | 6207 | 43 | -6.589 | 7.555 | 174 | Yes | - |
CDC5L | 988 | 34 | -3.419 | 5.672 | 155 | - | - |
HES4 | 57801 | 19 | -4.153 | 4.450 | 10 | - | - |
HPS3 | 84343 | 8 | -1.516 | 4.236 | 41 | - | - |
GOPC | 57120 | 19 | 1.749 | 4.450 | 68 | - | - |
CAPRIN1 | 4076 | 14 | -2.226 | 4.688 | 42 | - | - |
RPS24 | 6229 | 46 | -7.034 | 8.389 | 217 | Yes | - |
TUBA1C | 84790 | 10 | -4.660 | 6.242 | 91 | - | Yes |
RPS9 | 6203 | 45 | -7.127 | 7.555 | 140 | Yes | - |
PES1 | 23481 | 16 | 2.917 | 4.226 | 91 | - | - |
RPS4X | 6191 | 44 | -6.747 | 7.555 | 263 | Yes | - |
DNAJC10 | 54431 | 13 | -2.349 | 4.344 | 11 | - | - |
COPZ1 | 22818 | 48 | -8.301 | 9.063 | 13 | Yes | Yes |
YEATS4 | 8089 | 14 | -4.444 | 4.532 | 18 | Yes | Yes |
BRCA2 | 675 | 8 | -1.991 | 4.236 | 111 | - | - |
WDR46 | 9277 | 31 | -4.290 | 4.226 | 101 | Yes | Yes |
EIF2S3 | 1968 | 14 | -3.144 | 4.532 | 13 | Yes | - |
RPS27A | 6233 | 45 | -5.631 | 8.389 | 344 | Yes | - |
RPS14 | 6208 | 23 | -4.803 | 7.011 | 204 | Yes | - |
EIF3M | 10480 | 18 | 4.451 | 4.880 | 55 | Yes | - |
SRF | 6722 | 15 | 1.994 | 4.243 | 23 | - | - |
ACTB | 60 | 15 | -1.716 | 4.243 | 23 | - | - |
CTNND1 | 1500 | 16 | -2.651 | 4.226 | 53 | Yes | - |
UMPS | 7372 | 10 | 1.909 | 6.242 | 18 | - | - |
RPS26 | 6231 | 43 | -7.478 | 8.046 | 60 | Yes | - |
ARCN1 | 372 | 48 | -8.232 | 9.063 | 118 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
CDC42 | 998 | RPS27A | 6233 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
TNFRSF8 | 943 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
RPS20 | 6224 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
RPS4X | 6191 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
TUBA1C | 84790 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
EIF2S2 | 8894 | PES1 | 23481 | pp | -- | int.I2D: YeastLow |
PAFAH1B1 | 5048 | ARFGEF1 | 10565 | pd | > | reg.ITFP.txt: no annot |
RPS11 | 6205 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
ACTB | 60 | RPS4X | 6191 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | CANX | 821 | pd | < | reg.ITFP.txt: no annot |
COPA | 1314 | RB1 | 5925 | pd | <> | reg.ITFP.txt: no annot |
HSF1 | 3297 | SRF | 6722 | pd | <> | reg.ITFP.txt: no annot |
HSF1 | 3297 | SRF | 6722 | pp | -- | int.Yu: muscle |
RPS14 | 6208 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS13 | 6207 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
RPS23 | 6228 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS2 | 6187 | RPS14 | 6208 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BioGrid_Yeast |
CDC5L | 988 | CUL4B | 8450 | pd | <> | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS4X | 6191 | pp | -- | int.I2D: YeastHigh, YeastMedium, INTEROLOG |
RPS11 | 6205 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
WDR46 | 9277 | UTP18 | 51096 | pp | -- | int.I2D: YeastLow |
CDC5L | 988 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS14 | 6208 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RPS9 | 6203 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS15 | 6209 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS6 | 6194 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
ARCN1 | 372 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
RPS15 | 6209 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RB1 | 5925 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
CANX | 821 | ARFGEF1 | 10565 | pd | > | reg.ITFP.txt: no annot |
CANX | 821 | CAPRIN1 | 4076 | pd | > | reg.ITFP.txt: no annot |
RPS14 | 6208 | RPS20 | 6224 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BioGrid_Yeast |
RB1 | 5925 | HES4 | 57801 | pd | > | reg.pazar.txt: no annot |
RPS15 | 6209 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS9 | 6203 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RPS13 | 6207 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
RPS14 | 6208 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
EIF1AX | 1964 | RPS11 | 6205 | pp | -- | int.I2D: YeastMedium |
RPS4X | 6191 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
CHM | 1121 | COPA | 1314 | pd | < | reg.ITFP.txt: no annot |
RPS9 | 6203 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
EIF1AX | 1964 | EIF2S3 | 1968 | pd | > | reg.ITFP.txt: no annot |
RPS20 | 6224 | RPS23 | 6228 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS16 | 6217 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | SERBP1 | 26135 | pd | > | reg.pazar.txt: no annot |
RPS9 | 6203 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
MRPS12 | 6183 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium |
RPS13 | 6207 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | MRPS12 | 6183 | pp | -- | int.I2D: BioGrid_Yeast |
RPS15 | 6209 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
MRPS12 | 6183 | RPS2 | 6187 | pp | -- | int.I2D: YeastMedium |
RPS11 | 6205 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS23 | 6228 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast |
ACTB | 60 | RPS24 | 6229 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
UTP18 | 51096 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RAN | 5901 | RPS11 | 6205 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, MINT_Worm, NON_CORE |
RPS13 | 6207 | WDR46 | 9277 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
EIF1AX | 1964 | RPS15 | 6209 | pp | -- | int.I2D: YeastMedium |
RPS27A | 6233 | ARFGEF1 | 10565 | pp | -- | int.I2D: YeastLow |
RPS6 | 6194 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
CUL4B | 8450 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
RPS2 | 6187 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
PAFAH1B1 | 5048 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
PAFAH1B1 | 5048 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
RPS29 | 6235 | UMPS | 7372 | pp | -- | int.Intact: MI:0915(physical association) |
RPS27A | 6233 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
EIF1AX | 1964 | RPS2 | 6187 | pp | -- | int.I2D: YeastMedium |
MRPS12 | 6183 | RPS15 | 6209 | pp | -- | int.I2D: YeastMedium |
CAPRIN1 | 4076 | CKAP5 | 9793 | pd | < | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS2 | 6187 | RPS9 | 6203 | pp | -- | int.I2D: BIND_Yeast |
RPS24 | 6229 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
RPS11 | 6205 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | EIF3M | 10480 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
CDC42 | 998 | ARFGEF1 | 10565 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
RPS2 | 6187 | EIF3M | 10480 | pd | < | reg.ITFP.txt: no annot |
UMPS | 7372 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS16 | 6217 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
CANX | 821 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CTNND1 | 1500 | PES1 | 23481 | pd | <> | reg.ITFP.txt: no annot |
ACTB | 60 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
RPS20 | 6224 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS4X | 6191 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS20 | 6224 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS4X | 6191 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
EIF1AX | 1964 | YEATS4 | 8089 | pd | > | reg.ITFP.txt: no annot |
RAN | 5901 | RPS15 | 6209 | pp | -- | int.I2D: YeastLow |
EIF1AX | 1964 | RPS9 | 6203 | pp | -- | int.I2D: YeastMedium |
UMPS | 7372 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
ACTB | 60 | COPA | 1314 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | COPA | 1314 | pp | -- | int.I2D: BioGrid_Yeast |
CAPRIN1 | 4076 | CUL4B | 8450 | pd | < | reg.ITFP.txt: no annot |
RPS6 | 6194 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS2 | 6187 | RPS23 | 6228 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS6 | 6194 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RAN | 5901 | RPS2 | 6187 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, CORE_2, MINT_Worm |
COPA | 1314 | COPB1 | 1315 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastHigh |
CDC5L | 988 | CKAP5 | 9793 | pd | <> | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS20 | 6224 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS16 | 6217 | EIF3M | 10480 | pd | < | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
RAN | 5901 | WDR46 | 9277 | pp | -- | int.I2D: YeastLow |
RPS2 | 6187 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
PAFAH1B1 | 5048 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
RPS15 | 6209 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
DMD | 1756 | SRF | 6722 | pd | < | reg.pazar.txt: no annot; reg.TRANSFAC.txt: no annot |
RPS6 | 6194 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
CANX | 821 | RB1 | 5925 | pd | <> | reg.ITFP.txt: no annot |
RPS23 | 6228 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
BRCA2 | 675 | CTSF | 8722 | pd | > | reg.ITFP.txt: no annot |
RPS14 | 6208 | UTP18 | 51096 | pd | < | reg.ITFP.txt: no annot |
WDR46 | 9277 | PES1 | 23481 | pd | <> | reg.ITFP.txt: no annot |
ACTB | 60 | RAN | 5901 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, NON_CORE |
ACTB | 60 | PAFAH1B1 | 5048 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
CANX | 821 | MRPS12 | 6183 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | EIF1AX | 1964 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
CDC42 | 998 | GOPC | 57120 | pp | -- | int.I2D: BioGrid |
COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
COPB1 | 1315 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastMedium; int.DIP: MI:0915(physical association) |
CANX | 821 | COPA | 1314 | pd | <> | reg.ITFP.txt: no annot |
RPS15 | 6209 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
COPA | 1314 | CAPRIN1 | 4076 | pd | > | reg.ITFP.txt: no annot |
RPS2 | 6187 | RPS11 | 6205 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
EIF1AX | 1964 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium |
ACTB | 60 | ARCN1 | 372 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | EIF3M | 10480 | pd | < | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
EIF1AX | 1964 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast |
CDC5L | 988 | TLK2 | 11011 | pd | > | reg.ITFP.txt: no annot |
EIF1AX | 1964 | RPS14 | 6208 | pp | -- | int.I2D: YeastMedium |
CUL4B | 8450 | DNAJC10 | 54431 | pd | > | reg.ITFP.txt: no annot |
ACTB | 60 | YEATS4 | 8089 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
RPS13 | 6207 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
HSF1 | 3297 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
RB1 | 5925 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
COPA | 1314 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
CDC5L | 988 | GOPC | 57120 | pd | > | reg.ITFP.txt: no annot |
CTNND1 | 1500 | RPS2 | 6187 | pd | > | reg.ITFP.txt: no annot |
EIF1AX | 1964 | RPS16 | 6217 | pp | -- | int.I2D: YeastMedium |
RPS11 | 6205 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS2 | 6187 | RPS16 | 6217 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BioGrid_Yeast |
CDC5L | 988 | COPA | 1314 | pd | <> | reg.ITFP.txt: no annot |
COPA | 1314 | CUL4B | 8450 | pd | <> | reg.ITFP.txt: no annot |
RPS24 | 6229 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CDC5L | 988 | EIF2S2 | 8894 | pd | > | reg.ITFP.txt: no annot |
COPB1 | 1315 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid |
CHM | 1121 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
RPS13 | 6207 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
ARCN1 | 372 | COPB1 | 1315 | pp | -- | int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, BIND, BIND_Yeast, HPRD, Krogan_Core, MIPS; int.HPRD: in vivo |
BRCA2 | 675 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS9 | 6203 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid_Yeast |
RPS16 | 6217 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast |
RB1 | 5925 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
CANX | 821 | DCTN4 | 51164 | pd | > | reg.ITFP.txt: no annot |
RPS6 | 6194 | RPS20 | 6224 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
EIF2S3 | 1968 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
EIF1AX | 1964 | EIF3M | 10480 | pd | <> | reg.ITFP.txt: no annot |
CDC42 | 998 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
CANX | 821 | DNAJC10 | 54431 | pd | > | reg.ITFP.txt: no annot |
RPS4X | 6191 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
EIF3M | 10480 | ZC3H15 | 55854 | pd | > | reg.ITFP.txt: no annot |
CDC5L | 988 | RPS16 | 6217 | pp | -- | int.I2D: BioGrid |
COPA | 1314 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
COPB1 | 1315 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
COPA | 1314 | HPS3 | 84343 | pd | > | reg.ITFP.txt: no annot |
RPS16 | 6217 | RPS26 | 6231 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | ARFGEF1 | 10565 | pp | -- | int.I2D: BioGrid_Yeast |
ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
ACTB | 60 | SRF | 6722 | pd | < | reg.pazar.txt: no annot; reg.oreganno.txt: no annot |
RPS4X | 6191 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RAN | 5901 | PES1 | 23481 | pd | < | reg.ITFP.txt: no annot |
EIF2S3 | 1968 | EIF2S2 | 8894 | pp | -- | int.Intact: MI:0407(direct interaction); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, YeastHigh, Yu_GoldStd |
RPS11 | 6205 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS6 | 6194 | PES1 | 23481 | pp | -- | int.I2D: IntAct_Yeast |
RPS13 | 6207 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS24 | 6229 | RPS27A | 6233 | pp | -- | int.I2D: YeastMedium |
RPS27A | 6233 | EIF3M | 10480 | pd | < | reg.ITFP.txt: no annot |
COPA | 1314 | PAFAH1B1 | 5048 | pd | <> | reg.ITFP.txt: no annot |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0022627 | cytosolic small ribosomal subunit | 1.06e-27 | 1.74e-23 | 6.709 | 15 | 21 | 39 |
GO:0006413 | translational initiation | 6.15e-26 | 1.00e-21 | 5.302 | 19 | 27 | 131 |
GO:0019083 | viral transcription | 3.09e-22 | 5.05e-18 | 5.655 | 15 | 22 | 81 |
GO:0006415 | translational termination | 9.84e-22 | 1.61e-17 | 5.551 | 15 | 22 | 87 |
GO:0019058 | viral life cycle | 1.45e-21 | 2.36e-17 | 5.242 | 16 | 25 | 115 |
GO:0006414 | translational elongation | 2.88e-21 | 4.69e-17 | 5.455 | 15 | 22 | 93 |
GO:0006412 | translation | 5.93e-21 | 9.68e-17 | 4.459 | 19 | 29 | 235 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.71e-20 | 2.79e-16 | 5.294 | 15 | 22 | 104 |
GO:0003735 | structural constituent of ribosome | 4.36e-20 | 7.11e-16 | 4.948 | 16 | 24 | 141 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.27e-20 | 1.19e-15 | 5.162 | 15 | 22 | 114 |
GO:0044267 | cellular protein metabolic process | 2.31e-17 | 3.77e-13 | 3.529 | 21 | 29 | 495 |
GO:0044822 | poly(A) RNA binding | 1.07e-16 | 1.74e-12 | 2.768 | 27 | 42 | 1078 |
GO:0015935 | small ribosomal subunit | 4.86e-16 | 7.94e-12 | 7.000 | 8 | 9 | 17 |
GO:0016071 | mRNA metabolic process | 2.08e-15 | 3.39e-11 | 4.194 | 15 | 29 | 223 |
GO:0005829 | cytosol | 6.50e-15 | 1.06e-10 | 1.934 | 36 | 74 | 2562 |
GO:0016070 | RNA metabolic process | 9.49e-15 | 1.55e-10 | 4.046 | 15 | 29 | 247 |
GO:0016032 | viral process | 4.35e-13 | 7.09e-09 | 3.181 | 18 | 37 | 540 |
GO:0010467 | gene expression | 1.44e-12 | 2.34e-08 | 2.950 | 19 | 36 | 669 |
GO:0016020 | membrane | 1.83e-12 | 2.98e-08 | 2.125 | 28 | 48 | 1746 |
GO:0048205 | COPI coating of Golgi vesicle | 7.13e-10 | 1.16e-05 | 6.709 | 5 | 6 | 13 |
GO:0030126 | COPI vesicle coat | 7.13e-10 | 1.16e-05 | 6.709 | 5 | 6 | 13 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.84e-08 | 4.64e-04 | 5.766 | 5 | 6 | 25 |
GO:0005840 | ribosome | 7.40e-08 | 1.21e-03 | 4.790 | 6 | 10 | 59 |
GO:0042274 | ribosomal small subunit biogenesis | 7.99e-08 | 1.30e-03 | 6.503 | 4 | 6 | 12 |
GO:0005925 | focal adhesion | 8.88e-08 | 1.45e-03 | 3.016 | 11 | 23 | 370 |
GO:0061024 | membrane organization | 1.03e-06 | 1.68e-02 | 3.705 | 7 | 11 | 146 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.15e-06 | 1.87e-02 | 5.628 | 4 | 5 | 22 |
GO:0006364 | rRNA processing | 1.37e-06 | 2.24e-02 | 4.088 | 6 | 8 | 96 |
GO:0070062 | extracellular vesicular exosome | 1.33e-05 | 2.16e-01 | 1.314 | 23 | 51 | 2516 |
GO:0005515 | protein binding | 1.44e-05 | 2.35e-01 | 0.792 | 39 | 87 | 6127 |
GO:0003743 | translation initiation factor activity | 3.09e-05 | 5.04e-01 | 4.473 | 4 | 5 | 49 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 3.10e-05 | 5.05e-01 | 5.585 | 3 | 3 | 17 |
GO:0000056 | ribosomal small subunit export from nucleus | 3.98e-05 | 6.49e-01 | 7.503 | 2 | 2 | 3 |
GO:0005737 | cytoplasm | 4.67e-05 | 7.62e-01 | 0.988 | 29 | 65 | 3976 |
GO:0005730 | nucleolus | 8.03e-05 | 1.00e+00 | 1.457 | 17 | 36 | 1684 |
GO:0008135 | translation factor activity, nucleic acid binding | 9.05e-05 | 1.00e+00 | 5.088 | 3 | 4 | 24 |
GO:0043234 | protein complex | 1.11e-04 | 1.00e+00 | 2.666 | 7 | 9 | 300 |
GO:0019843 | rRNA binding | 1.30e-04 | 1.00e+00 | 4.918 | 3 | 4 | 27 |
GO:0033119 | negative regulation of RNA splicing | 1.32e-04 | 1.00e+00 | 6.766 | 2 | 2 | 5 |
GO:0045182 | translation regulator activity | 1.97e-04 | 1.00e+00 | 6.503 | 2 | 2 | 6 |
GO:0007097 | nuclear migration | 2.76e-04 | 1.00e+00 | 6.280 | 2 | 2 | 7 |
GO:0000028 | ribosomal small subunit assembly | 2.76e-04 | 1.00e+00 | 6.280 | 2 | 3 | 7 |
GO:0034332 | adherens junction organization | 3.09e-04 | 1.00e+00 | 4.503 | 3 | 4 | 36 |
GO:0005200 | structural constituent of cytoskeleton | 3.77e-04 | 1.00e+00 | 3.548 | 4 | 6 | 93 |
GO:0006886 | intracellular protein transport | 4.31e-04 | 1.00e+00 | 2.975 | 5 | 6 | 173 |
GO:0090136 | epithelial cell-cell adhesion | 4.71e-04 | 1.00e+00 | 5.918 | 2 | 2 | 9 |
GO:0030529 | ribonucleoprotein complex | 8.15e-04 | 1.00e+00 | 3.255 | 4 | 8 | 114 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.18e-03 | 1.00e+00 | 5.280 | 2 | 2 | 14 |
GO:0048821 | erythrocyte development | 1.35e-03 | 1.00e+00 | 5.181 | 2 | 2 | 15 |
GO:0031369 | translation initiation factor binding | 1.35e-03 | 1.00e+00 | 5.181 | 2 | 2 | 15 |
GO:0050998 | nitric-oxide synthase binding | 1.54e-03 | 1.00e+00 | 5.088 | 2 | 3 | 16 |
GO:0007067 | mitotic nuclear division | 1.58e-03 | 1.00e+00 | 2.558 | 5 | 7 | 231 |
GO:0075733 | intracellular transport of virus | 1.74e-03 | 1.00e+00 | 5.000 | 2 | 3 | 17 |
GO:0006612 | protein targeting to membrane | 1.96e-03 | 1.00e+00 | 4.918 | 2 | 2 | 18 |
GO:0017022 | myosin binding | 1.96e-03 | 1.00e+00 | 4.918 | 2 | 2 | 18 |
GO:0043473 | pigmentation | 2.42e-03 | 1.00e+00 | 4.766 | 2 | 2 | 20 |
GO:0003729 | mRNA binding | 2.45e-03 | 1.00e+00 | 3.483 | 3 | 3 | 73 |
GO:0009306 | protein secretion | 2.67e-03 | 1.00e+00 | 4.695 | 2 | 2 | 21 |
GO:0005198 | structural molecule activity | 2.77e-03 | 1.00e+00 | 2.775 | 4 | 5 | 159 |
GO:0030038 | contractile actin filament bundle assembly | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0000235 | astral microtubule | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0004588 | orotate phosphoribosyltransferase activity | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0090284 | positive regulation of protein glycosylation in Golgi | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0002183 | cytoplasmic translational initiation | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0022605 | oogenesis stage | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0043004 | cytoplasmic sequestering of CFTR protein | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0033593 | BRCA2-MAGE-D1 complex | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0051660 | establishment of centrosome localization | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0034975 | protein folding in endoplasmic reticulum | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0046016 | positive regulation of transcription by glucose | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0046469 | platelet activating factor metabolic process | 3.68e-03 | 1.00e+00 | 8.088 | 1 | 1 | 1 |
GO:0005844 | polysome | 3.78e-03 | 1.00e+00 | 4.444 | 2 | 2 | 25 |
GO:0045931 | positive regulation of mitotic cell cycle | 4.08e-03 | 1.00e+00 | 4.387 | 2 | 2 | 26 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 4.70e-03 | 1.00e+00 | 3.149 | 3 | 3 | 92 |
GO:0043967 | histone H4 acetylation | 4.72e-03 | 1.00e+00 | 4.280 | 2 | 2 | 28 |
GO:0007017 | microtubule-based process | 4.72e-03 | 1.00e+00 | 4.280 | 2 | 2 | 28 |
GO:0007093 | mitotic cell cycle checkpoint | 5.77e-03 | 1.00e+00 | 4.133 | 2 | 2 | 31 |
GO:0051219 | phosphoprotein binding | 6.14e-03 | 1.00e+00 | 4.088 | 2 | 4 | 32 |
GO:0003924 | GTPase activity | 6.58e-03 | 1.00e+00 | 2.422 | 4 | 6 | 203 |
GO:0010256 | endomembrane system organization | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0071987 | WD40-repeat domain binding | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0036035 | osteoclast development | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0014819 | regulation of skeletal muscle contraction | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0086001 | cardiac muscle cell action potential | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0051081 | nuclear envelope disassembly | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0001672 | regulation of chromatin assembly or disassembly | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0031134 | sister chromatid biorientation | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0010736 | serum response element binding | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 7.34e-03 | 1.00e+00 | 7.088 | 1 | 1 | 2 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 7.73e-03 | 1.00e+00 | 3.918 | 2 | 3 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 8.15e-03 | 1.00e+00 | 3.878 | 2 | 2 | 37 |
GO:0050681 | androgen receptor binding | 8.58e-03 | 1.00e+00 | 3.840 | 2 | 2 | 38 |
GO:0006184 | GTP catabolic process | 8.69e-03 | 1.00e+00 | 2.306 | 4 | 6 | 220 |
GO:0021766 | hippocampus development | 9.02e-03 | 1.00e+00 | 3.802 | 2 | 3 | 39 |
GO:0030521 | androgen receptor signaling pathway | 9.94e-03 | 1.00e+00 | 3.730 | 2 | 3 | 41 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:1900222 | negative regulation of beta-amyloid clearance | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0010484 | H3 histone acetyltransferase activity | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:1901385 | regulation of voltage-gated calcium channel activity | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0045505 | dynein intermediate chain binding | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0051683 | establishment of Golgi localization | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 2 | 3 |
GO:0070545 | PeBoW complex | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0031084 | BLOC-2 complex | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0033561 | regulation of water loss via skin | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0034663 | endoplasmic reticulum chaperone complex | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 2 | 3 |
GO:0021540 | corpus callosum morphogenesis | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0030687 | preribosome, large subunit precursor | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.10e-02 | 1.00e+00 | 6.503 | 1 | 1 | 3 |
GO:0034613 | cellular protein localization | 1.14e-02 | 1.00e+00 | 3.628 | 2 | 2 | 44 |
GO:0021762 | substantia nigra development | 1.24e-02 | 1.00e+00 | 3.564 | 2 | 2 | 46 |
GO:0008344 | adult locomotory behavior | 1.29e-02 | 1.00e+00 | 3.533 | 2 | 2 | 47 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.40e-02 | 1.00e+00 | 2.574 | 3 | 6 | 137 |
GO:0007030 | Golgi organization | 1.45e-02 | 1.00e+00 | 3.444 | 2 | 3 | 50 |
GO:0030490 | maturation of SSU-rRNA | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 2 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 2 | 4 |
GO:0034191 | apolipoprotein A-I receptor binding | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 2 | 4 |
GO:0048478 | replication fork protection | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0010669 | epithelial structure maintenance | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0015036 | disulfide oxidoreductase activity | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0016013 | syntrophin complex | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 2 | 4 |
GO:0006222 | UMP biosynthetic process | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0090231 | regulation of spindle checkpoint | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0072384 | organelle transport along microtubule | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 2 | 4 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0005968 | Rab-protein geranylgeranyltransferase complex | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 1.46e-02 | 1.00e+00 | 6.088 | 1 | 1 | 4 |
GO:0004197 | cysteine-type endopeptidase activity | 1.57e-02 | 1.00e+00 | 3.387 | 2 | 2 | 52 |
GO:0016042 | lipid catabolic process | 1.57e-02 | 1.00e+00 | 3.387 | 2 | 2 | 52 |
GO:0030175 | filopodium | 1.62e-02 | 1.00e+00 | 3.360 | 2 | 2 | 53 |
GO:0006457 | protein folding | 1.75e-02 | 1.00e+00 | 2.453 | 3 | 3 | 149 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.78e-02 | 1.00e+00 | 2.444 | 3 | 11 | 150 |
GO:0005654 | nucleoplasm | 1.79e-02 | 1.00e+00 | 1.161 | 9 | 26 | 1095 |
GO:0036336 | dendritic cell migration | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 3 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0044233 | ER-mitochondrion membrane contact site | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0035912 | dorsal aorta morphogenesis | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0043043 | peptide biosynthetic process | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0004663 | Rab geranylgeranyltransferase activity | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 5 |
GO:0045216 | cell-cell junction organization | 1.99e-02 | 1.00e+00 | 3.205 | 2 | 2 | 59 |
GO:0043353 | enucleate erythrocyte differentiation | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0007143 | female meiotic division | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0044458 | motile cilium assembly | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0051150 | regulation of smooth muscle cell differentiation | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0018344 | protein geranylgeranylation | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0060789 | hair follicle placode formation | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0008090 | retrograde axon cargo transport | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0051347 | positive regulation of transferase activity | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0010485 | H4 histone acetyltransferase activity | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0001667 | ameboidal-type cell migration | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0000974 | Prp19 complex | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0034452 | dynactin binding | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 1 | 6 |
GO:0006924 | activation-induced cell death of T cells | 2.19e-02 | 1.00e+00 | 5.503 | 1 | 2 | 6 |
GO:0006417 | regulation of translation | 2.25e-02 | 1.00e+00 | 3.110 | 2 | 4 | 63 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 2.39e-02 | 1.00e+00 | 2.280 | 3 | 4 | 168 |
GO:0030141 | secretory granule | 2.52e-02 | 1.00e+00 | 3.021 | 2 | 2 | 67 |
GO:0030424 | axon | 2.54e-02 | 1.00e+00 | 2.246 | 3 | 4 | 172 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0006893 | Golgi to plasma membrane transport | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0060055 | angiogenesis involved in wound healing | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0060136 | embryonic process involved in female pregnancy | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0043497 | regulation of protein heterodimerization activity | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0050658 | RNA transport | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0048027 | mRNA 5'-UTR binding | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0003334 | keratinocyte development | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0070914 | UV-damage excision repair | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0034101 | erythrocyte homeostasis | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0002162 | dystroglycan binding | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0017145 | stem cell division | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0000930 | gamma-tubulin complex | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0034259 | negative regulation of Rho GTPase activity | 2.55e-02 | 1.00e+00 | 5.280 | 1 | 1 | 7 |
GO:0034329 | cell junction assembly | 2.81e-02 | 1.00e+00 | 2.938 | 2 | 2 | 71 |
GO:0090009 | primitive streak formation | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0031512 | motile primary cilium | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0047498 | calcium-dependent phospholipase A2 activity | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0043589 | skin morphogenesis | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0007289 | spermatid nucleus differentiation | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0005869 | dynactin complex | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0051489 | regulation of filopodium assembly | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 1 | 8 |
GO:0000785 | chromatin | 2.96e-02 | 1.00e+00 | 2.898 | 2 | 2 | 73 |
GO:0019901 | protein kinase binding | 3.00e-02 | 1.00e+00 | 1.766 | 4 | 9 | 320 |
GO:0031175 | neuron projection development | 3.11e-02 | 1.00e+00 | 2.859 | 2 | 2 | 75 |
GO:0005525 | GTP binding | 3.24e-02 | 1.00e+00 | 1.730 | 4 | 6 | 328 |
GO:0097284 | hepatocyte apoptotic process | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 9 |
GO:0000983 | RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 9 |
GO:0000075 | cell cycle checkpoint | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 9 |
GO:0021895 | cerebral cortex neuron differentiation | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 9 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.26e-02 | 1.00e+00 | 2.821 | 2 | 4 | 77 |
GO:0005915 | zonula adherens | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 9 |
GO:0030837 | negative regulation of actin filament polymerization | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 9 |
GO:0032319 | regulation of Rho GTPase activity | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 9 |
GO:0045059 | positive thymic T cell selection | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 9 |
GO:0005813 | centrosome | 3.59e-02 | 1.00e+00 | 1.682 | 4 | 9 | 339 |
GO:0034237 | protein kinase A regulatory subunit binding | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0010225 | response to UV-C | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0051787 | misfolded protein binding | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0005798 | Golgi-associated vesicle | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 2 | 10 |
GO:0006996 | organelle organization | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0001076 | RNA polymerase II transcription factor binding transcription factor activity | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0090303 | positive regulation of wound healing | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0061029 | eyelid development in camera-type eye | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0001675 | acrosome assembly | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0060218 | hematopoietic stem cell differentiation | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0060047 | heart contraction | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 1 | 10 |
GO:0043197 | dendritic spine | 3.74e-02 | 1.00e+00 | 2.713 | 2 | 2 | 83 |
GO:0045502 | dynein binding | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 11 |
GO:0045176 | apical protein localization | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 11 |
GO:0017166 | vinculin binding | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 11 |
GO:0042551 | neuron maturation | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 11 |
GO:0035518 | histone H2A monoubiquitination | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 2 | 11 |
GO:0002011 | morphogenesis of an epithelial sheet | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 11 |
GO:0021819 | layer formation in cerebral cortex | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 11 |
GO:0003723 | RNA binding | 4.14e-02 | 1.00e+00 | 1.616 | 4 | 10 | 355 |
GO:0048471 | perinuclear region of cytoplasm | 4.28e-02 | 1.00e+00 | 1.379 | 5 | 9 | 523 |
GO:0007051 | spindle organization | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 2 | 12 |
GO:0043149 | stress fiber assembly | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 2 | 12 |
GO:0019082 | viral protein processing | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 2 | 12 |
GO:0030140 | trans-Golgi network transport vesicle | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 1 | 12 |
GO:0043968 | histone H2A acetylation | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 1 | 12 |
GO:0072583 | clathrin-mediated endocytosis | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 1 | 12 |
GO:0047496 | vesicle transport along microtubule | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 1 | 12 |
GO:0036150 | phosphatidylserine acyl-chain remodeling | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 1 | 12 |
GO:0055003 | cardiac myofibril assembly | 4.32e-02 | 1.00e+00 | 4.503 | 1 | 1 | 12 |
GO:0016363 | nuclear matrix | 4.50e-02 | 1.00e+00 | 2.564 | 2 | 4 | 92 |
GO:0042470 | melanosome | 4.50e-02 | 1.00e+00 | 2.564 | 2 | 2 | 92 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0001671 | ATPase activator activity | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.68e-02 | 1.00e+00 | 2.533 | 2 | 7 | 94 |
GO:0043488 | regulation of mRNA stability | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0001833 | inner cell mass cell proliferation | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0033290 | eukaryotic 48S preinitiation complex | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0042273 | ribosomal large subunit biogenesis | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0031929 | TOR signaling | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0032479 | regulation of type I interferon production | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 2 | 13 |
GO:0005662 | DNA replication factor A complex | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0036149 | phosphatidylinositol acyl-chain remodeling | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0035855 | megakaryocyte development | 4.68e-02 | 1.00e+00 | 4.387 | 1 | 1 | 13 |
GO:0001649 | osteoblast differentiation | 4.77e-02 | 1.00e+00 | 2.518 | 2 | 3 | 95 |
GO:0001764 | neuron migration | 4.86e-02 | 1.00e+00 | 2.503 | 2 | 2 | 96 |
GO:0030426 | growth cone | 4.95e-02 | 1.00e+00 | 2.488 | 2 | 3 | 97 |
GO:0035371 | microtubule plus-end | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0031333 | negative regulation of protein complex assembly | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0016282 | eukaryotic 43S preinitiation complex | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0060292 | long term synaptic depression | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0051298 | centrosome duplication | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0048488 | synaptic vesicle endocytosis | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0071480 | cellular response to gamma radiation | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0034185 | apolipoprotein binding | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0032465 | regulation of cytokinesis | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 1 | 14 |
GO:0030131 | clathrin adaptor complex | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0002042 | cell migration involved in sprouting angiogenesis | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0036148 | phosphatidylglycerol acyl-chain remodeling | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0016514 | SWI/SNF complex | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0045987 | positive regulation of smooth muscle contraction | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0045445 | myoblast differentiation | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0016010 | dystrophin-associated glycoprotein complex | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0008585 | female gonad development | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:2000114 | regulation of establishment of cell polarity | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 2 | 15 |
GO:0048854 | brain morphogenesis | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0060347 | heart trabecula formation | 5.38e-02 | 1.00e+00 | 4.181 | 1 | 1 | 15 |
GO:0005634 | nucleus | 5.43e-02 | 1.00e+00 | 0.435 | 24 | 66 | 4828 |
GO:0032839 | dendrite cytoplasm | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0007405 | neuroblast proliferation | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0032012 | regulation of ARF protein signal transduction | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0019226 | transmission of nerve impulse | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0000132 | establishment of mitotic spindle orientation | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 2 | 16 |
GO:0042176 | regulation of protein catabolic process | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 4 | 16 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0030220 | platelet formation | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0043623 | cellular protein complex assembly | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0050775 | positive regulation of dendrite morphogenesis | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 1 | 16 |
GO:0014069 | postsynaptic density | 5.80e-02 | 1.00e+00 | 2.360 | 2 | 3 | 106 |
GO:0030425 | dendrite | 5.83e-02 | 1.00e+00 | 1.766 | 3 | 3 | 240 |
GO:0000278 | mitotic cell cycle | 5.85e-02 | 1.00e+00 | 1.451 | 4 | 16 | 398 |
GO:0035255 | ionotropic glutamate receptor binding | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0033365 | protein localization to organelle | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0043274 | phospholipase binding | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0019068 | virion assembly | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 2 | 17 |
GO:0008306 | associative learning | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0031527 | filopodium membrane | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0001829 | trophectodermal cell differentiation | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0007141 | male meiosis I | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0030742 | GTP-dependent protein binding | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0001731 | formation of translation preinitiation complex | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0001556 | oocyte maturation | 6.07e-02 | 1.00e+00 | 4.000 | 1 | 1 | 17 |
GO:0030496 | midbody | 6.09e-02 | 1.00e+00 | 2.319 | 2 | 4 | 109 |
GO:0008134 | transcription factor binding | 6.19e-02 | 1.00e+00 | 1.730 | 3 | 5 | 246 |
GO:0000139 | Golgi membrane | 6.29e-02 | 1.00e+00 | 1.415 | 4 | 7 | 408 |
GO:0045773 | positive regulation of axon extension | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 18 |
GO:0005086 | ARF guanyl-nucleotide exchange factor activity | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 18 |
GO:0043015 | gamma-tubulin binding | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 2 | 18 |
GO:0010507 | negative regulation of autophagy | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 18 |
GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 18 |
GO:0090316 | positive regulation of intracellular protein transport | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 18 |
GO:0030532 | small nuclear ribonucleoprotein complex | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 18 |
GO:0043025 | neuronal cell body | 6.68e-02 | 1.00e+00 | 1.684 | 3 | 5 | 254 |
GO:0006259 | DNA metabolic process | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 19 |
GO:0007088 | regulation of mitosis | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 19 |
GO:0010165 | response to X-ray | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 19 |
GO:0017134 | fibroblast growth factor binding | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 2 | 19 |
GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 1 | 19 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 7.11e-02 | 1.00e+00 | 3.766 | 1 | 1 | 20 |
GO:0090398 | cellular senescence | 7.11e-02 | 1.00e+00 | 3.766 | 1 | 1 | 20 |
GO:0030544 | Hsp70 protein binding | 7.11e-02 | 1.00e+00 | 3.766 | 1 | 1 | 20 |
GO:0043021 | ribonucleoprotein complex binding | 7.45e-02 | 1.00e+00 | 3.695 | 1 | 1 | 21 |
GO:0007369 | gastrulation | 7.45e-02 | 1.00e+00 | 3.695 | 1 | 1 | 21 |
GO:0015035 | protein disulfide oxidoreductase activity | 7.45e-02 | 1.00e+00 | 3.695 | 1 | 1 | 21 |
GO:0000793 | condensed chromosome | 7.45e-02 | 1.00e+00 | 3.695 | 1 | 2 | 21 |
GO:0043034 | costamere | 7.45e-02 | 1.00e+00 | 3.695 | 1 | 1 | 21 |
GO:0046847 | filopodium assembly | 7.45e-02 | 1.00e+00 | 3.695 | 1 | 1 | 21 |
GO:0006325 | chromatin organization | 7.52e-02 | 1.00e+00 | 2.145 | 2 | 2 | 123 |
GO:0007220 | Notch receptor processing | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 2 | 22 |
GO:0005790 | smooth endoplasmic reticulum | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 22 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 22 |
GO:0030863 | cortical cytoskeleton | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 22 |
GO:0036151 | phosphatidylcholine acyl-chain remodeling | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 22 |
GO:0007052 | mitotic spindle organization | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 22 |
GO:0043065 | positive regulation of apoptotic process | 7.97e-02 | 1.00e+00 | 1.574 | 3 | 6 | 274 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 1 | 23 |
GO:0051491 | positive regulation of filopodium assembly | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 2 | 23 |
GO:0002040 | sprouting angiogenesis | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 1 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 1 | 23 |
GO:0008060 | ARF GTPase activator activity | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 1 | 23 |
GO:0001892 | embryonic placenta development | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 1 | 23 |
GO:0051297 | centrosome organization | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 2 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 8.13e-02 | 1.00e+00 | 3.564 | 1 | 1 | 23 |
GO:0030036 | actin cytoskeleton organization | 8.16e-02 | 1.00e+00 | 2.076 | 2 | 3 | 129 |
GO:0005761 | mitochondrial ribosome | 8.47e-02 | 1.00e+00 | 3.503 | 1 | 1 | 24 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 8.47e-02 | 1.00e+00 | 3.503 | 1 | 1 | 24 |
GO:0046329 | negative regulation of JNK cascade | 8.47e-02 | 1.00e+00 | 3.503 | 1 | 1 | 24 |
GO:0007163 | establishment or maintenance of cell polarity | 8.47e-02 | 1.00e+00 | 3.503 | 1 | 2 | 24 |
GO:0006206 | pyrimidine nucleobase metabolic process | 8.47e-02 | 1.00e+00 | 3.503 | 1 | 1 | 24 |
GO:0000790 | nuclear chromatin | 8.60e-02 | 1.00e+00 | 2.032 | 2 | 2 | 133 |
GO:0031982 | vesicle | 8.71e-02 | 1.00e+00 | 2.021 | 2 | 2 | 134 |
GO:0006611 | protein export from nucleus | 8.80e-02 | 1.00e+00 | 3.444 | 1 | 1 | 25 |
GO:0032781 | positive regulation of ATPase activity | 8.80e-02 | 1.00e+00 | 3.444 | 1 | 1 | 25 |
GO:0006654 | phosphatidic acid biosynthetic process | 8.80e-02 | 1.00e+00 | 3.444 | 1 | 1 | 25 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 8.80e-02 | 1.00e+00 | 3.444 | 1 | 2 | 25 |
GO:0007569 | cell aging | 8.80e-02 | 1.00e+00 | 3.444 | 1 | 1 | 25 |
GO:0045296 | cadherin binding | 8.80e-02 | 1.00e+00 | 3.444 | 1 | 1 | 25 |
GO:0005794 | Golgi apparatus | 9.01e-02 | 1.00e+00 | 1.065 | 5 | 8 | 650 |
GO:0000045 | autophagic vacuole assembly | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 1 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 2 | 26 |
GO:0045214 | sarcomere organization | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 1 | 26 |
GO:0045859 | regulation of protein kinase activity | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 1 | 26 |
GO:0005978 | glycogen biosynthetic process | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 2 | 26 |
GO:0048589 | developmental growth | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 1 | 26 |
GO:0001707 | mesoderm formation | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 1 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 2 | 26 |
GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane | 9.14e-02 | 1.00e+00 | 3.387 | 1 | 1 | 26 |
GO:0051149 | positive regulation of muscle cell differentiation | 9.47e-02 | 1.00e+00 | 3.333 | 1 | 2 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 9.47e-02 | 1.00e+00 | 3.333 | 1 | 1 | 27 |
GO:0007616 | long-term memory | 9.47e-02 | 1.00e+00 | 3.333 | 1 | 1 | 27 |
GO:0005083 | small GTPase regulator activity | 9.47e-02 | 1.00e+00 | 3.333 | 1 | 1 | 27 |
GO:0031424 | keratinization | 9.47e-02 | 1.00e+00 | 3.333 | 1 | 1 | 27 |
GO:0048565 | digestive tract development | 9.47e-02 | 1.00e+00 | 3.333 | 1 | 1 | 27 |
GO:0051258 | protein polymerization | 9.47e-02 | 1.00e+00 | 3.333 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 9.47e-02 | 1.00e+00 | 3.333 | 1 | 1 | 27 |
GO:0005911 | cell-cell junction | 9.60e-02 | 1.00e+00 | 1.938 | 2 | 2 | 142 |
GO:0032467 | positive regulation of cytokinesis | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 28 |
GO:0031492 | nucleosomal DNA binding | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 28 |
GO:0019894 | kinesin binding | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 28 |
GO:0005875 | microtubule associated complex | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 28 |
GO:0045597 | positive regulation of cell differentiation | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 1 | 28 |
GO:0031252 | cell leading edge | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 3 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 29 |
GO:0034605 | cellular response to heat | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 29 |
GO:0072686 | mitotic spindle | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 1 | 29 |
GO:0010332 | response to gamma radiation | 1.01e-01 | 1.00e+00 | 3.230 | 1 | 2 | 29 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.04e-01 | 1.00e+00 | 1.160 | 4 | 8 | 487 |
GO:0010977 | negative regulation of neuron projection development | 1.05e-01 | 1.00e+00 | 3.181 | 1 | 2 | 30 |
GO:0007346 | regulation of mitotic cell cycle | 1.05e-01 | 1.00e+00 | 3.181 | 1 | 3 | 30 |
GO:0031647 | regulation of protein stability | 1.05e-01 | 1.00e+00 | 3.181 | 1 | 1 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.05e-01 | 1.00e+00 | 3.181 | 1 | 1 | 30 |
GO:0002027 | regulation of heart rate | 1.05e-01 | 1.00e+00 | 3.181 | 1 | 2 | 30 |
GO:0040018 | positive regulation of multicellular organism growth | 1.05e-01 | 1.00e+00 | 3.181 | 1 | 1 | 30 |
GO:0010494 | cytoplasmic stress granule | 1.05e-01 | 1.00e+00 | 3.181 | 1 | 2 | 30 |
GO:0042981 | regulation of apoptotic process | 1.06e-01 | 1.00e+00 | 1.849 | 2 | 7 | 151 |
GO:0061077 | chaperone-mediated protein folding | 1.08e-01 | 1.00e+00 | 3.133 | 1 | 1 | 31 |
GO:0032480 | negative regulation of type I interferon production | 1.11e-01 | 1.00e+00 | 3.088 | 1 | 2 | 32 |
GO:0005788 | endoplasmic reticulum lumen | 1.14e-01 | 1.00e+00 | 1.793 | 2 | 2 | 157 |
GO:0070830 | tight junction assembly | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 1 | 33 |
GO:0033077 | T cell differentiation in thymus | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 1 | 33 |
GO:0001569 | patterning of blood vessels | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 1 | 34 |
GO:0007611 | learning or memory | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 2 | 34 |
GO:0001890 | placenta development | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 1.18e-01 | 1.00e+00 | 3.000 | 1 | 2 | 34 |
GO:0048666 | neuron development | 1.21e-01 | 1.00e+00 | 2.958 | 1 | 1 | 35 |
GO:0071333 | cellular response to glucose stimulus | 1.21e-01 | 1.00e+00 | 2.958 | 1 | 2 | 35 |
GO:0009725 | response to hormone | 1.21e-01 | 1.00e+00 | 2.958 | 1 | 1 | 35 |
GO:0051402 | neuron apoptotic process | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 1 | 36 |
GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 1 | 36 |
GO:0006446 | regulation of translational initiation | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 2 | 36 |
GO:0001895 | retina homeostasis | 1.24e-01 | 1.00e+00 | 2.918 | 1 | 1 | 36 |
GO:0003682 | chromatin binding | 1.25e-01 | 1.00e+00 | 1.289 | 3 | 4 | 334 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1.28e-01 | 1.00e+00 | 2.878 | 1 | 1 | 37 |
GO:0005791 | rough endoplasmic reticulum | 1.28e-01 | 1.00e+00 | 2.878 | 1 | 1 | 37 |
GO:0001568 | blood vessel development | 1.31e-01 | 1.00e+00 | 2.840 | 1 | 2 | 38 |
GO:0030218 | erythrocyte differentiation | 1.31e-01 | 1.00e+00 | 2.840 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 1.31e-01 | 1.00e+00 | 2.840 | 1 | 1 | 38 |
GO:0030049 | muscle filament sliding | 1.31e-01 | 1.00e+00 | 2.840 | 1 | 2 | 38 |
GO:0045740 | positive regulation of DNA replication | 1.31e-01 | 1.00e+00 | 2.840 | 1 | 1 | 38 |
GO:0007420 | brain development | 1.32e-01 | 1.00e+00 | 1.661 | 2 | 3 | 172 |
GO:0032092 | positive regulation of protein binding | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 1 | 39 |
GO:0031490 | chromatin DNA binding | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 1 | 39 |
GO:0060048 | cardiac muscle contraction | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 1 | 39 |
GO:0001933 | negative regulation of protein phosphorylation | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 1 | 39 |
GO:0007595 | lactation | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 1 | 39 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.37e-01 | 1.00e+00 | 2.766 | 1 | 1 | 40 |
GO:0007049 | cell cycle | 1.38e-01 | 1.00e+00 | 1.620 | 2 | 4 | 177 |
GO:0045211 | postsynaptic membrane | 1.38e-01 | 1.00e+00 | 1.620 | 2 | 3 | 177 |
GO:0005881 | cytoplasmic microtubule | 1.40e-01 | 1.00e+00 | 2.730 | 1 | 1 | 41 |
GO:0051117 | ATPase binding | 1.40e-01 | 1.00e+00 | 2.730 | 1 | 2 | 41 |
GO:0008307 | structural constituent of muscle | 1.40e-01 | 1.00e+00 | 2.730 | 1 | 1 | 41 |
GO:0017148 | negative regulation of translation | 1.40e-01 | 1.00e+00 | 2.730 | 1 | 1 | 41 |
GO:0050885 | neuromuscular process controlling balance | 1.40e-01 | 1.00e+00 | 2.730 | 1 | 1 | 41 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 1.40e-01 | 1.00e+00 | 2.730 | 1 | 4 | 41 |
GO:0031625 | ubiquitin protein ligase binding | 1.42e-01 | 1.00e+00 | 1.596 | 2 | 4 | 180 |
GO:0021987 | cerebral cortex development | 1.43e-01 | 1.00e+00 | 2.695 | 1 | 1 | 42 |
GO:0030155 | regulation of cell adhesion | 1.43e-01 | 1.00e+00 | 2.695 | 1 | 1 | 42 |
GO:0035914 | skeletal muscle cell differentiation | 1.43e-01 | 1.00e+00 | 2.695 | 1 | 1 | 42 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 1.47e-01 | 1.00e+00 | 2.661 | 1 | 2 | 43 |
GO:0004402 | histone acetyltransferase activity | 1.47e-01 | 1.00e+00 | 2.661 | 1 | 1 | 43 |
GO:0007286 | spermatid development | 1.50e-01 | 1.00e+00 | 2.628 | 1 | 1 | 44 |
GO:0005871 | kinesin complex | 1.50e-01 | 1.00e+00 | 2.628 | 1 | 1 | 44 |
GO:0050896 | response to stimulus | 1.50e-01 | 1.00e+00 | 2.628 | 1 | 1 | 44 |
GO:0008285 | negative regulation of cell proliferation | 1.52e-01 | 1.00e+00 | 1.153 | 3 | 3 | 367 |
GO:0043966 | histone H3 acetylation | 1.53e-01 | 1.00e+00 | 2.596 | 1 | 1 | 45 |
GO:0043547 | positive regulation of GTPase activity | 1.54e-01 | 1.00e+00 | 1.518 | 2 | 4 | 190 |
GO:0016328 | lateral plasma membrane | 1.56e-01 | 1.00e+00 | 2.564 | 1 | 3 | 46 |
GO:0044297 | cell body | 1.56e-01 | 1.00e+00 | 2.564 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.56e-01 | 1.00e+00 | 2.564 | 1 | 2 | 46 |
GO:0045727 | positive regulation of translation | 1.56e-01 | 1.00e+00 | 2.564 | 1 | 1 | 46 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.56e-01 | 1.00e+00 | 1.510 | 2 | 5 | 191 |
GO:0001047 | core promoter binding | 1.56e-01 | 1.00e+00 | 2.564 | 1 | 1 | 46 |
GO:0019003 | GDP binding | 1.62e-01 | 1.00e+00 | 2.503 | 1 | 1 | 48 |
GO:0001947 | heart looping | 1.65e-01 | 1.00e+00 | 2.473 | 1 | 1 | 49 |
GO:0034097 | response to cytokine | 1.68e-01 | 1.00e+00 | 2.444 | 1 | 1 | 50 |
GO:0001948 | glycoprotein binding | 1.68e-01 | 1.00e+00 | 2.444 | 1 | 2 | 50 |
GO:0035690 | cellular response to drug | 1.68e-01 | 1.00e+00 | 2.444 | 1 | 3 | 50 |
GO:0040008 | regulation of growth | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 1 | 51 |
GO:0000910 | cytokinesis | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 2 | 51 |
GO:0007254 | JNK cascade | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 3 | 51 |
GO:0003684 | damaged DNA binding | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 2 | 51 |
GO:0045732 | positive regulation of protein catabolic process | 1.71e-01 | 1.00e+00 | 2.415 | 1 | 1 | 51 |
GO:0045454 | cell redox homeostasis | 1.75e-01 | 1.00e+00 | 2.387 | 1 | 1 | 52 |
GO:0034976 | response to endoplasmic reticulum stress | 1.75e-01 | 1.00e+00 | 2.387 | 1 | 1 | 52 |
GO:0006952 | defense response | 1.78e-01 | 1.00e+00 | 2.360 | 1 | 1 | 53 |
GO:0030666 | endocytic vesicle membrane | 1.81e-01 | 1.00e+00 | 2.333 | 1 | 2 | 54 |
GO:0051403 | stress-activated MAPK cascade | 1.81e-01 | 1.00e+00 | 2.333 | 1 | 4 | 54 |
GO:0019900 | kinase binding | 1.81e-01 | 1.00e+00 | 2.333 | 1 | 3 | 54 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.81e-01 | 1.00e+00 | 2.333 | 1 | 1 | 54 |
GO:0050680 | negative regulation of epithelial cell proliferation | 1.81e-01 | 1.00e+00 | 2.333 | 1 | 1 | 54 |
GO:0008233 | peptidase activity | 1.84e-01 | 1.00e+00 | 2.306 | 1 | 1 | 55 |
GO:0000226 | microtubule cytoskeleton organization | 1.84e-01 | 1.00e+00 | 2.306 | 1 | 1 | 55 |
GO:0046330 | positive regulation of JNK cascade | 1.84e-01 | 1.00e+00 | 2.306 | 1 | 1 | 55 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 1.84e-01 | 1.00e+00 | 2.306 | 1 | 1 | 55 |
GO:0005783 | endoplasmic reticulum | 1.86e-01 | 1.00e+00 | 0.835 | 4 | 6 | 610 |
GO:0000932 | cytoplasmic mRNA processing body | 1.87e-01 | 1.00e+00 | 2.280 | 1 | 1 | 56 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 1.90e-01 | 1.00e+00 | 2.255 | 1 | 1 | 57 |
GO:0000724 | double-strand break repair via homologous recombination | 1.90e-01 | 1.00e+00 | 2.255 | 1 | 2 | 57 |
GO:0030097 | hemopoiesis | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 1 | 58 |
GO:0016197 | endosomal transport | 1.93e-01 | 1.00e+00 | 2.230 | 1 | 3 | 58 |
GO:0051087 | chaperone binding | 1.96e-01 | 1.00e+00 | 2.205 | 1 | 1 | 59 |
GO:0005643 | nuclear pore | 1.96e-01 | 1.00e+00 | 2.205 | 1 | 1 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.96e-01 | 1.00e+00 | 2.205 | 1 | 1 | 59 |
GO:0010976 | positive regulation of neuron projection development | 1.99e-01 | 1.00e+00 | 2.181 | 1 | 2 | 60 |
GO:0032481 | positive regulation of type I interferon production | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 3 | 61 |
GO:0003705 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 1 | 61 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 1 | 61 |
GO:0006302 | double-strand break repair | 2.04e-01 | 1.00e+00 | 2.133 | 1 | 2 | 62 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 2.04e-01 | 1.00e+00 | 2.133 | 1 | 1 | 62 |
GO:0000776 | kinetochore | 2.07e-01 | 1.00e+00 | 2.110 | 1 | 3 | 63 |
GO:0019221 | cytokine-mediated signaling pathway | 2.07e-01 | 1.00e+00 | 1.242 | 2 | 5 | 230 |
GO:0007059 | chromosome segregation | 2.10e-01 | 1.00e+00 | 2.088 | 1 | 3 | 64 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.10e-01 | 1.00e+00 | 2.088 | 1 | 2 | 64 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.13e-01 | 1.00e+00 | 2.065 | 1 | 6 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 2.13e-01 | 1.00e+00 | 2.065 | 1 | 5 | 65 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.13e-01 | 1.00e+00 | 2.065 | 1 | 6 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 2.13e-01 | 1.00e+00 | 2.065 | 1 | 5 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 2.13e-01 | 1.00e+00 | 2.065 | 1 | 1 | 65 |
GO:0005882 | intermediate filament | 2.16e-01 | 1.00e+00 | 2.043 | 1 | 3 | 66 |
GO:0071260 | cellular response to mechanical stimulus | 2.16e-01 | 1.00e+00 | 2.043 | 1 | 3 | 66 |
GO:0043202 | lysosomal lumen | 2.16e-01 | 1.00e+00 | 2.043 | 1 | 1 | 66 |
GO:0009636 | response to toxic substance | 2.16e-01 | 1.00e+00 | 2.043 | 1 | 1 | 66 |
GO:0031295 | T cell costimulation | 2.19e-01 | 1.00e+00 | 2.021 | 1 | 3 | 67 |
GO:0003713 | transcription coactivator activity | 2.19e-01 | 1.00e+00 | 1.187 | 2 | 6 | 239 |
GO:0006338 | chromatin remodeling | 2.22e-01 | 1.00e+00 | 2.000 | 1 | 2 | 68 |
GO:0045666 | positive regulation of neuron differentiation | 2.22e-01 | 1.00e+00 | 2.000 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 2.25e-01 | 1.00e+00 | 1.979 | 1 | 4 | 69 |
GO:0018105 | peptidyl-serine phosphorylation | 2.25e-01 | 1.00e+00 | 1.979 | 1 | 5 | 69 |
GO:0006289 | nucleotide-excision repair | 2.25e-01 | 1.00e+00 | 1.979 | 1 | 1 | 69 |
GO:0050790 | regulation of catalytic activity | 2.25e-01 | 1.00e+00 | 1.979 | 1 | 1 | 69 |
GO:0006887 | exocytosis | 2.25e-01 | 1.00e+00 | 1.979 | 1 | 1 | 69 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.28e-01 | 1.00e+00 | 1.958 | 1 | 8 | 70 |
GO:0035264 | multicellular organism growth | 2.28e-01 | 1.00e+00 | 1.958 | 1 | 1 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 2.31e-01 | 1.00e+00 | 1.938 | 1 | 5 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 2.31e-01 | 1.00e+00 | 1.938 | 1 | 5 | 71 |
GO:0042383 | sarcolemma | 2.31e-01 | 1.00e+00 | 1.938 | 1 | 2 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 2.33e-01 | 1.00e+00 | 1.918 | 1 | 5 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 2.36e-01 | 1.00e+00 | 1.898 | 1 | 5 | 73 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.36e-01 | 1.00e+00 | 1.898 | 1 | 6 | 73 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.36e-01 | 1.00e+00 | 1.898 | 1 | 2 | 73 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.39e-01 | 1.00e+00 | 1.878 | 1 | 8 | 74 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 2.39e-01 | 1.00e+00 | 1.878 | 1 | 1 | 74 |
GO:0002020 | protease binding | 2.39e-01 | 1.00e+00 | 1.878 | 1 | 1 | 74 |
GO:0007265 | Ras protein signal transduction | 2.42e-01 | 1.00e+00 | 1.859 | 1 | 3 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 2.42e-01 | 1.00e+00 | 1.859 | 1 | 2 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 2.45e-01 | 1.00e+00 | 1.840 | 1 | 5 | 76 |
GO:0046474 | glycerophospholipid biosynthetic process | 2.45e-01 | 1.00e+00 | 1.840 | 1 | 2 | 76 |
GO:0044325 | ion channel binding | 2.47e-01 | 1.00e+00 | 1.821 | 1 | 3 | 77 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.47e-01 | 1.00e+00 | 1.821 | 1 | 6 | 77 |
GO:0006914 | autophagy | 2.47e-01 | 1.00e+00 | 1.821 | 1 | 1 | 77 |
GO:0008584 | male gonad development | 2.47e-01 | 1.00e+00 | 1.821 | 1 | 1 | 77 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 2.50e-01 | 1.00e+00 | 1.802 | 1 | 5 | 78 |
GO:0017137 | Rab GTPase binding | 2.50e-01 | 1.00e+00 | 1.802 | 1 | 1 | 78 |
GO:0071013 | catalytic step 2 spliceosome | 2.53e-01 | 1.00e+00 | 1.784 | 1 | 1 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.53e-01 | 1.00e+00 | 1.784 | 1 | 8 | 79 |
GO:0006281 | DNA repair | 2.53e-01 | 1.00e+00 | 1.043 | 2 | 5 | 264 |
GO:0010629 | negative regulation of gene expression | 2.56e-01 | 1.00e+00 | 1.766 | 1 | 2 | 80 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 2.56e-01 | 1.00e+00 | 1.766 | 1 | 5 | 80 |
GO:0034138 | toll-like receptor 3 signaling pathway | 2.56e-01 | 1.00e+00 | 1.766 | 1 | 5 | 80 |
GO:0007565 | female pregnancy | 2.56e-01 | 1.00e+00 | 1.766 | 1 | 1 | 80 |
GO:0051301 | cell division | 2.58e-01 | 1.00e+00 | 1.748 | 1 | 2 | 81 |
GO:0045177 | apical part of cell | 2.61e-01 | 1.00e+00 | 1.730 | 1 | 1 | 82 |
GO:0030336 | negative regulation of cell migration | 2.64e-01 | 1.00e+00 | 1.713 | 1 | 2 | 83 |
GO:0007517 | muscle organ development | 2.64e-01 | 1.00e+00 | 1.713 | 1 | 1 | 83 |
GO:0005179 | hormone activity | 2.67e-01 | 1.00e+00 | 1.695 | 1 | 1 | 84 |
GO:0007283 | spermatogenesis | 2.70e-01 | 1.00e+00 | 0.979 | 2 | 2 | 276 |
GO:0047485 | protein N-terminus binding | 2.72e-01 | 1.00e+00 | 1.661 | 1 | 1 | 86 |
GO:0007160 | cell-matrix adhesion | 2.77e-01 | 1.00e+00 | 1.628 | 1 | 1 | 88 |
GO:0050852 | T cell receptor signaling pathway | 2.77e-01 | 1.00e+00 | 1.628 | 1 | 2 | 88 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 2.77e-01 | 1.00e+00 | 1.628 | 1 | 3 | 88 |
GO:0042593 | glucose homeostasis | 2.80e-01 | 1.00e+00 | 1.612 | 1 | 1 | 89 |
GO:0000187 | activation of MAPK activity | 2.83e-01 | 1.00e+00 | 1.596 | 1 | 3 | 90 |
GO:0000922 | spindle pole | 2.85e-01 | 1.00e+00 | 1.580 | 1 | 5 | 91 |
GO:0018279 | protein N-linked glycosylation via asparagine | 2.85e-01 | 1.00e+00 | 1.580 | 1 | 1 | 91 |
GO:0016337 | single organismal cell-cell adhesion | 2.88e-01 | 1.00e+00 | 1.564 | 1 | 2 | 92 |
GO:0006928 | cellular component movement | 2.88e-01 | 1.00e+00 | 1.564 | 1 | 4 | 92 |
GO:0016605 | PML body | 2.88e-01 | 1.00e+00 | 1.564 | 1 | 2 | 92 |
GO:0007264 | small GTPase mediated signal transduction | 2.89e-01 | 1.00e+00 | 0.908 | 2 | 7 | 290 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 2.91e-01 | 1.00e+00 | 1.548 | 1 | 1 | 93 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.95e-01 | 1.00e+00 | 0.541 | 4 | 9 | 748 |
GO:0051082 | unfolded protein binding | 2.96e-01 | 1.00e+00 | 1.518 | 1 | 1 | 95 |
GO:0034142 | toll-like receptor 4 signaling pathway | 2.99e-01 | 1.00e+00 | 1.503 | 1 | 5 | 96 |
GO:0071456 | cellular response to hypoxia | 3.04e-01 | 1.00e+00 | 1.473 | 1 | 3 | 98 |
GO:0016568 | chromatin modification | 3.06e-01 | 1.00e+00 | 1.458 | 1 | 2 | 99 |
GO:0051726 | regulation of cell cycle | 3.14e-01 | 1.00e+00 | 1.415 | 1 | 2 | 102 |
GO:0004888 | transmembrane signaling receptor activity | 3.17e-01 | 1.00e+00 | 1.401 | 1 | 1 | 103 |
GO:0005856 | cytoskeleton | 3.17e-01 | 1.00e+00 | 0.807 | 2 | 6 | 311 |
GO:0005096 | GTPase activator activity | 3.29e-01 | 1.00e+00 | 1.333 | 1 | 3 | 108 |
GO:0002224 | toll-like receptor signaling pathway | 3.32e-01 | 1.00e+00 | 1.319 | 1 | 5 | 109 |
GO:0005938 | cell cortex | 3.32e-01 | 1.00e+00 | 1.319 | 1 | 1 | 109 |
GO:0005815 | microtubule organizing center | 3.34e-01 | 1.00e+00 | 1.306 | 1 | 4 | 110 |
GO:0007411 | axon guidance | 3.39e-01 | 1.00e+00 | 0.734 | 2 | 3 | 327 |
GO:0015630 | microtubule cytoskeleton | 3.39e-01 | 1.00e+00 | 1.280 | 1 | 4 | 112 |
GO:0005819 | spindle | 3.44e-01 | 1.00e+00 | 1.255 | 1 | 4 | 114 |
GO:0043231 | intracellular membrane-bounded organelle | 3.46e-01 | 1.00e+00 | 0.713 | 2 | 3 | 332 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.48e-01 | 1.00e+00 | 0.424 | 4 | 11 | 811 |
GO:0072562 | blood microparticle | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 1 | 116 |
GO:0097190 | apoptotic signaling pathway | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 3 | 116 |
GO:0000209 | protein polyubiquitination | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 7 | 116 |
GO:0005802 | trans-Golgi network | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 2 | 116 |
GO:0005635 | nuclear envelope | 3.49e-01 | 1.00e+00 | 1.230 | 1 | 2 | 116 |
GO:0006006 | glucose metabolic process | 3.56e-01 | 1.00e+00 | 1.193 | 1 | 4 | 119 |
GO:0032496 | response to lipopolysaccharide | 3.63e-01 | 1.00e+00 | 1.157 | 1 | 1 | 122 |
GO:0016192 | vesicle-mediated transport | 3.63e-01 | 1.00e+00 | 1.157 | 1 | 1 | 122 |
GO:0006351 | transcription, DNA-templated | 3.64e-01 | 1.00e+00 | 0.265 | 7 | 17 | 1585 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 3.65e-01 | 1.00e+00 | 1.145 | 1 | 3 | 123 |
GO:0007568 | aging | 3.65e-01 | 1.00e+00 | 1.145 | 1 | 2 | 123 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.69e-01 | 1.00e+00 | 0.470 | 3 | 9 | 589 |
GO:0005509 | calcium ion binding | 3.69e-01 | 1.00e+00 | 0.470 | 3 | 4 | 589 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 3.70e-01 | 1.00e+00 | 1.122 | 1 | 3 | 125 |
GO:0007219 | Notch signaling pathway | 3.70e-01 | 1.00e+00 | 1.122 | 1 | 4 | 125 |
GO:0007050 | cell cycle arrest | 3.72e-01 | 1.00e+00 | 1.110 | 1 | 2 | 126 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.75e-01 | 1.00e+00 | 1.099 | 1 | 3 | 127 |
GO:0008201 | heparin binding | 3.75e-01 | 1.00e+00 | 1.099 | 1 | 1 | 127 |
GO:0030054 | cell junction | 3.78e-01 | 1.00e+00 | 0.612 | 2 | 4 | 356 |
GO:0015031 | protein transport | 3.79e-01 | 1.00e+00 | 0.608 | 2 | 4 | 357 |
GO:0030027 | lamellipodium | 3.82e-01 | 1.00e+00 | 1.065 | 1 | 3 | 130 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 3.82e-01 | 1.00e+00 | 1.065 | 1 | 4 | 130 |
GO:0046983 | protein dimerization activity | 3.84e-01 | 1.00e+00 | 1.054 | 1 | 3 | 131 |
GO:0045087 | innate immune response | 3.96e-01 | 1.00e+00 | 0.406 | 3 | 11 | 616 |
GO:0006644 | phospholipid metabolic process | 3.98e-01 | 1.00e+00 | 0.990 | 1 | 3 | 137 |
GO:0045202 | synapse | 4.04e-01 | 1.00e+00 | 0.958 | 1 | 1 | 140 |
GO:0007507 | heart development | 4.06e-01 | 1.00e+00 | 0.948 | 1 | 1 | 141 |
GO:0016055 | Wnt signaling pathway | 4.06e-01 | 1.00e+00 | 0.948 | 1 | 3 | 141 |
GO:0008286 | insulin receptor signaling pathway | 4.13e-01 | 1.00e+00 | 0.918 | 1 | 4 | 144 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 4.22e-01 | 1.00e+00 | 0.878 | 1 | 3 | 148 |
GO:0008284 | positive regulation of cell proliferation | 4.24e-01 | 1.00e+00 | 0.473 | 2 | 7 | 392 |
GO:0010628 | positive regulation of gene expression | 4.24e-01 | 1.00e+00 | 0.868 | 1 | 4 | 149 |
GO:0008017 | microtubule binding | 4.26e-01 | 1.00e+00 | 0.859 | 1 | 2 | 150 |
GO:0001666 | response to hypoxia | 4.26e-01 | 1.00e+00 | 0.859 | 1 | 1 | 150 |
GO:0051260 | protein homooligomerization | 4.26e-01 | 1.00e+00 | 0.859 | 1 | 2 | 150 |
GO:0030246 | carbohydrate binding | 4.28e-01 | 1.00e+00 | 0.849 | 1 | 1 | 151 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 4.28e-01 | 1.00e+00 | 0.849 | 1 | 2 | 151 |
GO:0010008 | endosome membrane | 4.41e-01 | 1.00e+00 | 0.793 | 1 | 2 | 157 |
GO:0006974 | cellular response to DNA damage stimulus | 4.43e-01 | 1.00e+00 | 0.784 | 1 | 3 | 158 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 4.45e-01 | 1.00e+00 | 0.775 | 1 | 3 | 159 |
GO:0006508 | proteolysis | 4.47e-01 | 1.00e+00 | 0.408 | 2 | 2 | 410 |
GO:0043005 | neuron projection | 4.49e-01 | 1.00e+00 | 0.757 | 1 | 6 | 161 |
GO:0045121 | membrane raft | 4.49e-01 | 1.00e+00 | 0.757 | 1 | 3 | 161 |
GO:0008022 | protein C-terminus binding | 4.49e-01 | 1.00e+00 | 0.757 | 1 | 4 | 161 |
GO:0000398 | mRNA splicing, via spliceosome | 4.57e-01 | 1.00e+00 | 0.721 | 1 | 2 | 165 |
GO:0034220 | ion transmembrane transport | 4.61e-01 | 1.00e+00 | 0.704 | 1 | 2 | 167 |
GO:0007601 | visual perception | 4.63e-01 | 1.00e+00 | 0.695 | 1 | 1 | 168 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 4.69e-01 | 1.00e+00 | 0.670 | 1 | 3 | 171 |
GO:0043066 | negative regulation of apoptotic process | 4.75e-01 | 1.00e+00 | 0.329 | 2 | 14 | 433 |
GO:0016607 | nuclear speck | 4.77e-01 | 1.00e+00 | 0.636 | 1 | 2 | 175 |
GO:0031965 | nuclear membrane | 4.79e-01 | 1.00e+00 | 0.628 | 1 | 2 | 176 |
GO:0019904 | protein domain specific binding | 4.88e-01 | 1.00e+00 | 0.588 | 1 | 3 | 181 |
GO:0043687 | post-translational protein modification | 4.88e-01 | 1.00e+00 | 0.588 | 1 | 1 | 181 |
GO:0005764 | lysosome | 4.90e-01 | 1.00e+00 | 0.580 | 1 | 2 | 182 |
GO:0015629 | actin cytoskeleton | 4.92e-01 | 1.00e+00 | 0.572 | 1 | 3 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 4.94e-01 | 1.00e+00 | 0.564 | 1 | 5 | 184 |
GO:0008150 | biological_process | 5.06e-01 | 1.00e+00 | 0.245 | 2 | 3 | 459 |
GO:0007596 | blood coagulation | 5.12e-01 | 1.00e+00 | 0.230 | 2 | 5 | 464 |
GO:0006468 | protein phosphorylation | 5.16e-01 | 1.00e+00 | 0.220 | 2 | 6 | 467 |
GO:0030168 | platelet activation | 5.32e-01 | 1.00e+00 | 0.408 | 1 | 4 | 205 |
GO:0001701 | in utero embryonic development | 5.41e-01 | 1.00e+00 | 0.373 | 1 | 2 | 210 |
GO:0042802 | identical protein binding | 5.43e-01 | 1.00e+00 | 0.148 | 2 | 4 | 491 |
GO:0003677 | DNA binding | 5.61e-01 | 1.00e+00 | 0.010 | 5 | 14 | 1351 |
GO:0007399 | nervous system development | 5.97e-01 | 1.00e+00 | 0.151 | 1 | 1 | 245 |
GO:0005874 | microtubule | 6.16e-01 | 1.00e+00 | 0.076 | 1 | 3 | 258 |
GO:0005102 | receptor binding | 6.30e-01 | 1.00e+00 | 0.021 | 1 | 2 | 268 |
GO:0000166 | nucleotide binding | 6.36e-01 | 1.00e+00 | 0.000 | 1 | 2 | 272 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 6.37e-01 | 1.00e+00 | -0.005 | 1 | 5 | 273 |
GO:0005975 | carbohydrate metabolic process | 6.39e-01 | 1.00e+00 | -0.010 | 1 | 3 | 274 |
GO:0003779 | actin binding | 6.40e-01 | 1.00e+00 | -0.016 | 1 | 3 | 275 |
GO:0019899 | enzyme binding | 6.57e-01 | 1.00e+00 | -0.082 | 1 | 5 | 288 |
GO:0030198 | extracellular matrix organization | 6.66e-01 | 1.00e+00 | -0.117 | 1 | 1 | 295 |
GO:0042803 | protein homodimerization activity | 6.68e-01 | 1.00e+00 | -0.182 | 2 | 4 | 617 |
GO:0004674 | protein serine/threonine kinase activity | 6.87e-01 | 1.00e+00 | -0.198 | 1 | 6 | 312 |
GO:0035556 | intracellular signal transduction | 6.92e-01 | 1.00e+00 | -0.221 | 1 | 5 | 317 |
GO:0005575 | cellular_component | 6.98e-01 | 1.00e+00 | -0.243 | 1 | 2 | 322 |
GO:0030154 | cell differentiation | 7.02e-01 | 1.00e+00 | -0.257 | 1 | 3 | 325 |
GO:0008283 | cell proliferation | 7.08e-01 | 1.00e+00 | -0.283 | 1 | 4 | 331 |
GO:0044281 | small molecule metabolic process | 7.11e-01 | 1.00e+00 | -0.251 | 4 | 16 | 1295 |
GO:0007275 | multicellular organismal development | 7.22e-01 | 1.00e+00 | -0.339 | 1 | 2 | 344 |
GO:0007268 | synaptic transmission | 7.31e-01 | 1.00e+00 | -0.376 | 1 | 1 | 353 |
GO:0005886 | plasma membrane | 7.37e-01 | 1.00e+00 | -0.211 | 9 | 24 | 2834 |
GO:0007155 | cell adhesion | 7.61e-01 | 1.00e+00 | -0.497 | 1 | 3 | 384 |
GO:0006355 | regulation of transcription, DNA-templated | 7.81e-01 | 1.00e+00 | -0.436 | 3 | 10 | 1104 |
GO:0009986 | cell surface | 7.93e-01 | 1.00e+00 | -0.634 | 1 | 1 | 422 |
GO:0045892 | negative regulation of transcription, DNA-templated | 7.94e-01 | 1.00e+00 | -0.640 | 1 | 2 | 424 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.95e-01 | 1.00e+00 | -0.644 | 1 | 3 | 425 |
GO:0055114 | oxidation-reduction process | 8.34e-01 | 1.00e+00 | -0.822 | 1 | 2 | 481 |
GO:0055085 | transmembrane transport | 8.54e-01 | 1.00e+00 | -0.918 | 1 | 3 | 514 |
GO:0007165 | signal transduction | 8.72e-01 | 1.00e+00 | -0.804 | 2 | 7 | 950 |
GO:0006915 | apoptotic process | 8.82e-01 | 1.00e+00 | -1.070 | 1 | 9 | 571 |
GO:0005615 | extracellular space | 8.93e-01 | 1.00e+00 | -0.893 | 2 | 3 | 1010 |
GO:0005576 | extracellular region | 9.05e-01 | 1.00e+00 | -0.947 | 2 | 4 | 1049 |
GO:0005789 | endoplasmic reticulum membrane | 9.08e-01 | 1.00e+00 | -1.225 | 1 | 3 | 636 |
GO:0008270 | zinc ion binding | 9.10e-01 | 1.00e+00 | -0.972 | 2 | 7 | 1067 |
GO:0046872 | metal ion binding | 9.15e-01 | 1.00e+00 | -0.844 | 3 | 14 | 1465 |
GO:0005524 | ATP binding | 9.65e-01 | 1.00e+00 | -1.315 | 2 | 19 | 1354 |
GO:0005887 | integral component of plasma membrane | 9.74e-01 | 1.00e+00 | -1.821 | 1 | 2 | 961 |
GO:0005739 | mitochondrion | 9.81e-01 | 1.00e+00 | -1.943 | 1 | 10 | 1046 |
GO:0016021 | integral component of membrane | 1.00e+00 | 1.00e+00 | -3.190 | 1 | 4 | 2483 |